Hydroxychloroquine does not increase the risk of arrhythmia, a large study in Arthritis & Rheumatology has found. The study was precipitated by controversy surrounding hydroxychloroquine and a ...

Introduction The increasing incidence of type 2 diabetes mellitus (T2DM) among women of reproductive age poses significant health risks for both mothers and their fetuses. Optimising blood glucose ...

Current use of hydroxychloroquine is associated with a lower risk for myocardial infarction (MI), stroke, and other thromboembolic events in patients with systemic lupus erythematosus (SLE). This ...

Iowans will be able to weigh in on the bill during a public subcommittee hearing scheduled for Tuesday at 12:15 p.m. in Room ...

A new study found a connection between lower doses of hydroxychloroquine (HCQ) and increased risk of hospitalization in people with active systemic lupus erythematosus (SLE). HCQ (known commercially ...

A state lawmaker wants the South Dakota Legislature to address how ivermectin and hydroxychloroquine are dispensed to ...

The optimal hydroxychloroquine blood level in lupus is between 750 ng/mL and 1,150 ng/mL, which can help prevent active ...

A discredited study that set off a flurry of interest in using an antimalarial drug to treat COVID-19 has now been formally withdrawn. A scientific journal on Tuesday retracted the March 2020 study ...

A recent study found that regularly checking blood levels of hydroxychloroquine (HCQ, known commercially as Plaquenil®) may reduce the need for emergency room visits and hospitalizations for people ...

BENGALURU (Reuters) - India has lifted an export ban on hydroxychloroquine, the anti-malarial drug touted by U.S. President Donald Trump as a potential "game changer" in the fight against the COVID-19 ...